Traumatic brain injury (TBI) produces excessive glutamate, leading to excitotoxicity via the activation of glutamate receptors. Postsynaptic density scaffold proteins have crucial roles in mediating signal transduction from glutamate receptors to their downstream mediators. Therefore, studies on the mechanisms underlying regulation of excitotoxicity by scaffold proteins can uncover new treatments for TBI. Here, we demonstrated that the postsynaptic scaffold protein Homer 1a was neuroprotective against TBI in vitro and in vivo, and this neuroprotection was associated with its effects on group I metabotropic glutamate receptors (mGluRs). Upon further study, we found that Homer 1a mainly affected neuronal injury induced by mGluR1 activation after TBI and also influenced mGluR5 function when its activity was restored. The ability of Homer 1a to disrupt mGluR-ERK signaling contributed to its ability to regulate the functions of mGluR1 and mGluR5 after traumatic injury. Intracellular Ca 2 þ and PKC were two important factors involved in the mediation of mGluR-ERK signaling by Homer 1a. These results define Homer 1a as a novel endogenous neuroprotective agent against TBI.
Traumatic brain injury (TBI) is the most common neurological disease and leads to acute neuronal cell injury, resulting in brain damage and neurological deficits. Glutamate-induced excitotoxicity excessively stimulates glutamate receptors, including the N-methyl-D-aspartate receptor (NMDAR), the a-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor and the metabotropic glutamate receptor (mGluR), as well as their downstream signaling cascades, which have prominent roles in TBI. 1 Although basic research studies have shown that various antagonists of glutamate receptors are effective in attenuating neuronal cell death and improving neurological function after TBI, these drugs have not performed satisfactorily in clinical investigations and cause some side effects. 2 Recently, promising compounds that uncouple postsynaptic scaffold protein PSD-95 from the NMDAR-related neurotoxic signaling pathway have demonstrated effective neuroprotection in the treatment of stroke, another severe acute brain injury. [3] [4] [5] Therefore, the disruption of glutamate receptor signaling by targeting postsynaptic scaffold proteins also provides a novel strategy for inhibiting excitotoxicity caused by TBI. Unlike PSD-95, the role of the scaffold protein Homer, which regulates mGluR signaling, in brain injuries has not been elucidated. Homer proteins are characterized by a conserved enabled/vasodilator-stimulated phosphoprotein (Ena/VASP) homology 1 (EVH1) domain. [6] [7] [8] [9] However, the variation at the carboxy terminus determines the distinct function of Homer proteins. In mGluR signaling, long Homer variants (Homer 1b/c, Homer 2, and Homer 3) with a coiledcoil homodimerization domain at the carboxy terminus functionally link mGluR and its downstream mediators via their EVH1 domains. 7, 8, 10, 11 In contrast, a short Homer variant (Homer 1a) without the coiled-coil domain cannot establish the linkage between the two target proteins via its EVH1 domain; 7, 8, 10, 11 thus, it acts as a dominant-negative protein that disrupts the crosslinking action of mGluR-Homer signaling. 12 This regulatory model has been demonstrated in several neurological diseases, including inflammatory pain 13, 14 and fragile X syndrome, 15 which raises the question of how Homer 1a is involved in regulating mGluR signaling in TBI. Here, we reported the neuroprotective role of Homer 1a in TBI and the involvement of group I mGluR signaling.
Results
Effects of Homer 1a on neuronal injury after traumatic injury. To determine the expression of Homer 1a during traumatic injury in cortical neurons, we used a transection model, which has been reported to result in mechanical neuronal injury and primary neuronal death and considered as an in vitro model of neuronal trauma. 16 Homer 1a mRNA expression in mouse cortical neuronal cultures, as assessed by real-time polymerase chain reaction (PCR), increased after traumatic injury (Figure 1a ), which was consistent with our previous observation in rat cortical neurons. Homer 1a protein expression also increased after neuronal injury (Figure 1b ). Both Homer 1a mRNA and protein followed a similar pattern of expression, peaking at 6 h after traumatic injury. Immunofluorescence staining also showed strong immunoreactivity of Homer 1a in the cytoplasm and dendrites at 6 h after traumatic injury (Figure 1c ).
Because elevation of Homer 1a protein expression was observed during traumatic injury, we speculated that this induction of Homer 1a might have some effects on neuronal survival and death. Lentiviral transduction of Flag-tagged Homer 1a (Flag-H1a) increased the expression of Homer 1a protein (Figures 1d and e ), which inhibited the reduction of cell viability (Figure 1f ), attenuated cytotoxicity (release of LDH) ( Figure 1g ), and cell death (propidium iodide (PI) positive staining) ( Figure 1h ) in neurons undergoing traumatic injury. To further clarify the effects of endogenous Homer 1a on traumatic injury, the expression of Homer 1a protein was knocked down by a lentivirally expressed shRNA targeting Homer 1a (shRNA H1a) (Figures 1d and e ). The shRNA H1a aggravated the neuronal injury after traumatic injury (Figures 1f-h). Furthermore, the overexpression of human Homer 1a rescued the effects of shRNA H1a, confirming the specificity of the shRNA-mediated knockdown of mouse Homer 1a. Taken together, these results indicate that Homer 1a is an endogenous neuroprotective protein in traumatic injury.
Homer 1a ameliorated brain damage and improved neurological function after TBI. To determine whether Homer 1a has similar effects in vivo, we used a closed head injury model to mimic TBI (Figure 2a ). We found that Homer 1a protein expression was also increased in the cortex around the lesion (Figure 2b ). Moreover, immunostaining indicated that induction of Homer 1a was also observed in the hippocampus surrounding the lesion area (Figures 2c and d ). Next, we infused lentiviruses containing Flag-H1a into the right cortex of mice. After 5 days, western blot and immunofluorescence analyses revealed that Homer 1a was overexpressed in the right cortex of the mice (Figures 2e and f) . Then, brain trauma was induced in the right hemisphere, and the water content of the brain was measured at 6 h, 1 day, 3 days, and 7 days after TBI. Neurological severity score (NSS) of the mice was assessed for seven consecutive days after injury. Lentiviral transduction of Flag-H1a in the lesion hemisphere significantly reduced brain edema and neurological deficits (Figures 2g and h). Furthermore, overexpression of Homer 1a decreased the duration of edema and neurological dysfunction. These results indicate the neuroprotective effects of Homer 1a overexpression in brain trauma.
The regulation of neuronal injury by Homer 1a was associated with group I mGluRs. A large number of studies have shown that mGluRs have crucial roles in TBI. After traumatic injury, we found that activation of group I mGluRs contributed to the neuronal injury after traumatic injury, whereas activation of either group II mGluRs or group III mGluRs inhibited the neuronal injury (Supplementary Figure S1 ). Then, we tested whether Homer 1a regulates the function of mGluRs after traumatic injury. In the presence of an antagonist of group I mGluRs (AIDA), neither overexpression nor knockdown of Figure 1 Homer 1a is neuroprotective in vitro. Traumatic injury was induced in mice neuronal cultures for 48 h. The expression of Homer 1a mRNA was measured by realtime PCR (a), and the expression of Homer 1a protein was measured by western blot analysis (b). The data are represented as the mean ± S.E.M. from five experiments. *Po0.05 versus control. The distribution of Homer 1a and MAP2 (neurons) before and after traumatic injury is shown via immunofluorescence staining (c). DAPI was used to stain the nuclei. Scale bar ¼ 20 mm. The expression of Homer 1a was assessed by western blot in cortical neurons expressing different lentiviruses (d and e). After transfection and traumatic injury, cell viability was measured by the WST assay (f), cytotoxicity was determined by the lactate dehydrogenase (LDH) assay (g) and the cell death rate was assessed by PI/Hoechst staining (h Although the activation of group I mGluRs promoted neuronal injury, two subtypes of group I mGluRs (mGluR1 and mGluR5) are thought to have distinct roles in TBI (Supplementary Figure S2 ). Here, we hypothesized that Homer 1a might differentially regulate these two subtypes of group I mGluRs. Overexpression of Homer 1a attenuated the neuronal injury in neurons pretreated with mGluR5 These results indicate that the inactivation of mGluR1 by Homer 1a overpowered the similar effects of Homer 1a on the activity of mGluR5 after traumatic injury. However, Homer 1a also influenced the function of mGluR5 when its function was restored.
The disruption of mGluR1-ERK signaling by Homer 1a protected against traumatic injury. As an important intracellular signaling pathway, the ERK pathway is a crucial component of downstream mGluR1/5 signal transduction, which has been implicated in the regulation of TBI in vitro and in vivo. Here, we found that an mGluR1 antagonist (Bay 36-7620) inhibited the activation of the ERK pathway in neurons undergoing traumatic injury (Figure 5a ), whereas an mGluR1 agonist (Ro 67-7476) increased the phosphorylation of ERK in normal neuronal cultures ( Figure 5b ). On the other hand, ERK inhibitors (PD98059 and U0126) reduced the neuronal injury in neurons treated with an mGluR1 agonist (Ro 67-7476) (Figures 5c-e). Therefore, activation of mGluR1-ERK signaling might contribute to neuronal injury after traumatic injury.
According to previous results, the neuroprotective effect of Homer 1a is mainly dependent on its inhibition of mGluR1 function in traumatic injury. The overexpression of Homer 1a reduced the activation of the ERK pathway after traumatic injury, whereas phosphorylation of ERK was increased by knockdown of Homer 1a under the same conditions (Figure 5f ). Similarly, ERK phosphorylation induced by an mGluR1 agonist Figure 5g ). Hence, disruption of mGluR1-ERK by Homer 1a could be a potential mechanism underlying the neuroprotective effect of Homer 1a in traumatic neuronal injury.
Homer 1a interfered mGluR5 agonist-induced ERK activation after traumatic injury. Unlike the inactivation of mGluR1, the mGluR5 antagonist MPEP did not affect the ERK pathway in neuronal cultures subjected to traumatic injury ( Figure 6a ). In contrast, an mGluR5 agonist (CHPG) Using the ERK inhibitors PD98059 and U0126, neuronal injury was increased in neuronal cultures treated with mGluR5 agonist after traumatic injury (Figures 6d-f ). These results suggest that mGluR5-ERK signaling has a role in mGluR5 agonist-induced neuroprotection against traumatic injury.
Owing to the ability of Homer 1a to regulate the effects of the mGluR5 agonist, we assumed that mGluR5-ERK signaling in neuroprotection would also be disrupted by Homer 1a. In normal neuronal cultures, mGluR5 agonistinduced elevation of ERK phosphorylation was inhibited by the overexpression of Homer 1a and augmented by knockdown of Homer 1a (Figure 6g ). After pretreatment of neuronal cultures undergoing traumatic injury with an mGluR5 agonist (CHPG) and an mGluR1 antagonist (Bay 36-7620), Homer 1a overexpression and knockdown exerted similar effects on the ERK pathway ( Figure 6h ). Taken together, these results demonstrate that Homer 1a is also involved in the regulation of mGluR5-ERK signaling-associated neuroprotection.
Involvement of Ca 2 þ in the regulation of mGluR1-ERK signaling by Homer 1a. Intracellular Ca 2 þ is an important mediator of mGluR-ERK signaling. Using an intracellular Ca 2 þ chelator (BAPTA-AM), we found that neuronal injury was attenuated in neuronal cultures undergoing traumatic injury ( Figure 7a ). Hence, we speculated that Ca 2 þ was involved in the mediation of mGluR1-ERK signaling owing to its consistent effects on traumatic injury. Next, we observed Figure 7b ). Moreover, mGluR1 agonistinduced phosphorylation of ERK was reduced using an intracellular Ca 2 þ chelator (BAPTA-AM, 10 mM) ( Figure 7c ). These results suggest that the elevation of intracellular Ca 2 þ induced by the activation of mGluR1 contributes to mGluR1 signaling to the ERK pathway during traumatic injury.
Next, we further investigated whether Homer 1a disrupted mGluR1-ERK by regulating the levels of intracellular Ca 2 þ . After traumatic injury, overexpression of Homer 1a attenuated Ca 2 þ overload (Figure 7d ), whereas knockdown of Homer 1a enhanced the Ca 2 þ response in neuronal cultures (Figure 7e ). However, in the presence of an mGluR1 antagonist (Bay 36-7620), these effects were no longer significant (Figures 7f and g) . In addition, the mGluR1 agonist-induced elevation of Ca 2 þ was also reduced by Homer 1a overexpression and enhanced by Homer 1a knockdown in normal neuronal cultures (Figures 7h and i) .
Therefore, we concluded that Homer 1a regulates mGluR1-Ca 2 þ -ERK signaling, providing a mechanism for the role of Homer 1a in traumatic neuronal injury.
Homer 1a interfered with PKC-dependent ERK activation by an mGluR5 agonist. In addition to Ca 2 þ , PKC is also reportedly involved in mGluR-ERK signaling. After traumatic injury, we observed that the inhibition of PKC activity by chelerythrine chloride (CTC) had no significant effect on neuronal injury (Figure 8a) . In contrast, a PKC activator (Bryostatin 1) protected neurons from traumatic injury ( Figure 8a ). Furthermore, we found that PKC inhibition reduced the mGluR5 agonist-induced elevation of ERK phosphorylation ( Figure 8b ) and mGluR5 agonist increased the activity of PKC (Figure 8c ). These results support the hypothesis that PKC regulates mGluR5-ERK signaling.
Next, we further examined whether Homer 1a influences PKC-dependent ERK activation in the presence of an mGluR5 agonist. After pretreatment with an mGluR5 agonist (CHPG), (Figure 8d ). Moreover, the mGluR5 agonist-induced elevation of PKC activity was also decreased by Homer 1a overexpression and increased by Homer 1a knockdown in normal neuronal cultures (Figure 8e ). In contrast, the regulation of Homer 1a expression did not alter the activity of PKC induced by a PKC activator (Bryostatin 1) ( Figure 8f ). Taken together, these results indicate that Homer 1a regulates mGluR5-PKC-ERK signaling by interfering with mGluR5 function.
Discussion
The involvement of mGluRs in models of TBI in vitro and in vivo has been well established in several previous studies. [17] [18] [19] [20] [21] [22] In the present study, we revealed that Homer 1a selectively interfered with the actions of mGluRs during TBI. First, the upregulation of Homer 1a attenuated the neuronal injury induced by activation of group I mGluRs, suggesting that the protective effect of Homer 1a against traumatic injury was related to its regulation of group I mGluRs. Second, the beneficial effect on neuronal survival induced by agonists of group II mGluRs and group III mGluRs was not affected by Homer 1a upregulation, which may be because neither group II mGluRs nor group III mGluRs lack the target sequence for Homer (PPXXF) at their C-termini. The discovery that altered Homer 1a was responsible for much of the regulation of group I mGluRs in neuronal injury demonstrated that the neuroprotective effects of Homer 1a against traumatic injury were associated with the regulation of group I mGluR signaling. There are two subtypes of group I mGluRs, including mGluR1 and mGluR5. Previous studies have reported that mGluR1 contributed to neuronal injury after TBI using mGluR1-specific agonists and antagonists. [18] [19] [20] 23 In addition, many studies showed that mGluR5-specific agonists had therapeutic effects on TBI in vitro and in vivo. [24] [25] [26] [27] In the present study, we observed that mGluR1 and mGluR5 had different functions, suggesting that the activation of mGluR1 enhanced neuronal injury and the activation of mGluR5 protected neurons from trauma. According to this theory, the inhibition of mGluR5 by antagonists would promote neuronal injury after traumatic injury. However, our results showed that inactivation of mGluR5 had no significant effects on neuronal injury. Hence, we speculated that the activity of mGluR5 was blocked after traumatic neuronal injury; thus, mGluR1 was the major group I mGluR involved in neuronal injury.
Because both mGluR1 and mGluR5 contain the Homerspecific target sequence, they can interact with Homer scaffold proteins. 8 Homer 1a has been reported to regulate the function of both mGluR1 and mGluR5. 13 In the present study, the upregulation of Homer 1a reduced the neuronal injury induced by activation of mGluR1, supporting the notion that Homer 1a exerts protective effects against traumatic injury. In theory, Homer 1a should promote the function of mGluR5 during traumatic injury because they are both neuroprotective proteins. However, in the case of mGluR1 inhibition, Homer 1a inhibited the protective effects of an mGluR5 agonist. This result was consistent with observations from previous studies, which confirmed that Homer 1a negatively regulates the function of mGluR5 in other neurological diseases. 15, 28 Considering that the effects of mGluR1 overpowered the action of mGluR5 after traumatic neuronal injury, it is possible that the enhanced activation of mGluR1 limited the regulatory effect of Homer 1a on mGluR5. Therefore, inactivation of mGluR1 by Homer 1a mainly contributed to its neuroprotective effects against traumatic injury.
Group I mGluRs can activate a large number of downstream modulators and signaling pathways. 29 Among these modulators and signaling pathways, the ERK pathway is thought to be closely related to the regulation of TBI. In previous studies, the level of ERK phosphorylation was enhanced, and inhibition of the ERK pathway reduced the cortical lesion and the neuronal injury after TBI. [30] [31] [32] In the present study, we observed that mGluR1 was mainly responsible for the activation of ERK pathway by group I mGluRs after traumatic injury. However, this result does not indicate whether the mGluR5-activated ERK pathway would participate in the regulation of TBI. In recent studies, we revealed that an mGluR5 agonist could enhance the activation of the ERK pathway after TBI, and an ERK pathway inhibitor attenuated the protective effects of an mGluR5 agonist against neuronal injury. 24, 25 These results suggest that the specific function of mGluR-ERK signaling during trauma is dependent on the subtypes of activated mGluRs.
Accumulating evidence has demonstrated that Homer scaffold proteins coordinate mGluR-ERK signaling under various conditions. 14, 15, 33 Homer 1a is thought to downregulate the increase in the intracellular Ca 2 þ response 9, 34 and negatively regulate the phosphorylation of ERK, 14, 15, 35 both of which are associated with the regulation of mGluR function. Moreover, our previous studies demonstrated that Homer 1a attenuated the overload of Ca 2 þ induced by injurious stimulations, including excitotoxicity and oxidative stress. 36, 37 However, the role of Ca 2 þ in the regulation of mGluR-ERK by Homer 1a is still not fully understood in the context of neuronal injury. Presumably, Ca 2 þ mainly engages in mGluR1 signaling after traumatic injury owing to the similar effects of Ca 2 þ overload and mGluR1 activation in traumatic injury. The present study provides evidence that intracellular Ca 2 þ overload contributes to the mGluR1-induced activation of ERK after traumatic injury, and upregulation of Homer 1a disrupts mGluR1-ERK signaling by inhibiting the release of intracellular Ca 2 þ in response to neuronal injury.
Although the mGluR5-induced Ca 2 þ response could also be negatively regulated by Homer 1a under some conditions, 14 this mechanism might be weakened in traumatic injury owing to the opposing effects of Ca 2 þ response and mGluR5 activation. Therefore, the ability of Homer 1a to modify mGluR1-ERK signaling raises the question as to whether the Homer 1a-mediated phosphorylation of ERK in response to mGluR5 activation occurs in a Ca 2 þ -independent manner. In our previous study, we confirmed the neuroprotective role of mGluR5-PKC-ERK signaling in TBI. 24 Accordingly, we further verified the role of Homer 1a in the regulation of mGluR5-PKC-ERK signaling, indicating that Homer 1a also participates in the regulation of ERK phosphorylation by disrupting the signaling from mGluR5 to PKC in traumatic injury. Thus, the effects of Homer 1a on traumatic injury would be reversed once mGluR5 function is restored, indicating that there might be a more complicated mechanism underlying the regulation of group I mGluRs by Homer 1a (Supplementary Figure S4) .
Dysregulation of mGluR is implicated in multiple brain disorders. 38 Therefore, many selective mGluR antagonists have been developed for clinical therapy. However, these drugs have produced some unacceptable side effects in clinical trials. The present study indicated that Homer 1a may be a potential neuroprotective agent against TBI via its regulation of mGluR1. Because the regulation of mGluR by Homer 1a had more specific and mild effects compared with a direct blockade of mGluR, the side effects caused by inactivation of mGluR might be reduced to some extent. However, the ability of Homer 1a to disrupt mGluR5 signaling indicates that it may have potential side effects in therapy when the function of mGluR5 is restored during recovery phase after TBI. This is because mGluR5 has important roles in regulating normal neurological function. Thus, further investigation is required to elucidate the relationship between Homer 1a and mGluR in neurological diseases.
Materials and Methods
Antibodies and reagents. Primary antibody against Homer 1a was obtained from Santa Cruz Biotechnology (Dallas, TX, USA). Antibodies against phosphor-ERK1/2 (p-ERK) and total ERK1/2 (ERK) were obtained from Cell Signaling Technology (Danvers, MA, USA). Antibody against b-actin was obtained from Sigma (St Louis, MO, USA). The secondary antibodies for immunoblotting were horseradish peroxidase-conjugated anti-rabbit and anti-goat IgG (Santa Cruz Biotechnology). The secondary antibodies for immunostaining were Alexa 488 donkey anti-goat IgG and Alex 594 donkey anti-rabbit IgG) (Invitrogen, Carlsbad, CA, USA). Agonists and antagonists were obtained from Tocris Bioscience (Bristol, UK).
Animals. C57BL/6 mice (10-12 weeks, 25-28 g) were obtained from Experimental Center of Fourth Military Medical University, which were kept at a constant temperature (approximately 27 1C) in an air-conditioned room for at least 7 days before the study and were exposed to a 12-h light/dark cycle. All animal studies were performed in adherence with the National Institutes of Health Guidelines on the Use of Laboratory Animals, and were approved by the Fourth Military Medical University Committee on Animal Care.
Primary culture of cortical neurons. Neuronal cortical cultures were prepared as previously described with some modifications. Briefly, cerebral cortices were removed from embryos at 16-18 days. Tissues were dissociated by 0.25% trypsin digestion for 15 min at 37 1C and gentle trituration. Neurons were resuspended in the Neurobasal medium containing 2% B27 supplement and 0.5 mM L-glutamine (Invitrogen) and plated at a density of 3 Â 10 5 cells per cm 2 . Before seeding, culture vessels, consisting of 96-well plates, 1.5 cm glass slides or 6 cm dishes were coated with poly-L-lysine (50 mg/ml) at room temperature overnight. Neurons were maintained at 37 1C in a humidified 5% CO 2 incubator and half of the culture medium was changed every other day. The cultured neurons were used for studies on in vitro days 12-14 (DIV 12-14) and verified to be 495%.
Traumatic neuronal injury model. The in vivo model of TBI used in the present study was previously described by Mukhin et al. 16 with some modification. The transection model used a plastic stylet to scrape adherent cells from a culture dish thereby tearing processes and soma while leaving a significant proportion of cells intact. A transection model was used in the present study as described previously. 32 Briefly, each dish confluent culture was manually scratched with a sterile plastic pipette tip following a square grid (with 3 mm spacing between the lines). To reduce the inconsistency of damage in different experiments, all traumatic neuronal injury models were established by the same researcher in our group by using a standard square grid module. Cell cultures were placed in an incubator at 37 1C until a designated posttrauma time point was reached. Cultures were incubated without changing the medium. Experiments were performed from 0 h (immediately after mechanical injury) to 48 h after trauma. Uninjured cultures were used as controls. Because scratch injury activates neurons first at the wound edge and later expands to the entire neuron monolayer, the entire culture on each dish was used for all experiments.
Real-time reverse transcription-PCR. RNA was isolated from primary cortical neurons by Trizol (Invitrogen). After equalization of the RNA quantity in each group, the reverse-transcription and real-time PCR were performed using a commercially available kit (TaKaRa, Dalian, China). Following cDNA generation, quantitative PCR was completed with the Bio-Rad iQ5 Gradient Real-Time PCR system (Bio-Rad Laboratories, Hercules, CA, USA). Primers for all PCR experiments was listed as follows: Homer1a primers, 5 0 -GGCAAACACTGTTTATG GACTGG-3 0 (forward), 5 0 -GTAATTCAGTCAACTTGAGCAACC-3 0 (reverse); b-actin primers, 5 0 -CTAAGGCCAACCGTGAAAAGATG-3 0 (forward), 5 0 -ACCGCTCGTTG CCAATAGTGATG-3 0 (reverse). Fifty cycles were used for quantitative PCR, using conditions: 94 1C (30 s), 58 1C (30 s) and 72 1C (30 s). The relative intensity against b-actin and the fold change relative to the control were calculated.
Western blot analysis. Western blot analysis was performed as described previously. Briefly, the entire neurons on each well in vitro and the impaired cortexes of the mice in vivo were lysed with a lysis buffer with protease inhibitor (Roche, Penzberg, Germany). Equivalent amounts of protein were loaded and separated by 8-12% SDS-PAGE gels, and transferred to nitrocellulose membranes (Invitrogen). The membranes were incubated overnight at 4 1C with the appropriate primary antibody (Homer 1a, 1:200; b-actin, 1:2500; p-ERK, 1:800; ERK, 1:1000). Membranes were washed in TBST and incubated for 1 h at room temperature with the secondary antibodies. Immunoreactivity was detected by SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific, Waltham, MA, USA). The membranes were stripped for 15 min at room temperature with Re-blot Plus Strong Solution (Thermo Scientific) and retested with tubulin or b-actin antibodies to normalize for protein loading. The optical densities of the bands were quantified by using an image analysis system with ImageJ (National Institutes of Health, Bethesda, MD, USA).
Immunocytochemistry. After fixing with 4% paraformaldehyde for 15 min at 37 1C, mice neuronal cultures were washed with phosphate-buffered saline (PBS) and permeabilized with 0.2% Triton X-100, followed by incubation of primary antibodies overnight at 4 1C. The primary antibodies were diluted as follows: Homer 1a (1:50) and MAP-2 (1:200). Then, cells were incubated with secondary antibodies (Alexa 488 donkey-anti-goat IgG (Invitrogen), 1:300; Alexa-594conjugated goat-anti-mouse IgG, 1:300) for 2 h. Cultures were dehydrated with ethanol and mounted with 4,6-diamidino-2-phenylindole (DAPI) for nuclear staining (Sigma). Images were captured using an Olympus FV10i Confocal Microscope (Olympus, Tokyo, Japan). All images from one experiment were acquired using the same exposure time to allow comparisons of relative levels of immunoreactivity between the different treatment conditions. At least six images of each group were taken by an evaluator blinded to the experimental conditions. Cell viability assay. Cell viability assay was performed by using The Cell Proliferation Reagent WST-1 (Roche) following the manufacturer's protocol. Cells (at a concentration of 0.5-5 Â 10 5 ) were cultured in 24-well plates with a final volume of 500 ml per well in the culture medium. After treatment, 50 ml cell proliferation reagent WST-1 was added to each well and incubated for 4 h at 37 1C in 5% CO 2 , and then shaken thoroughly for 1 min on a shaker. One hundred and ten microliters of supernatant from each well was collected to a 96-well microplate. The absorbance of the samples was measured by using a microplate reader (Bio-Rad Laboratories).
Cytotoxicity assay. LDH release assay was used for the measurement of cytotoxicity. LDH release into the culture medium was detected using a diagnostic kit (Jiancheng Bioengineering Institute, Nanjing, China) according to the manufacturer's instructions. Briefly, 50 ml of supernatant from each well was collected to assay LDH release. The samples were incubated with reduced form of nicotinamide-adenine dinucleotide and pyruvate for 15 min at 37 1C and the reaction was stopped by adding 0.4 mol/l NaOH. The activity of LDH was calculated from the absorbance at 440 nm, and background absorbance from the culture medium that was not used for any cell cultures was subtracted from all absorbance measurements. The results were normalized to the maximal LDH release, which was determined by treating control wells for 60 min with 1% Triton X-100 to lyse all cells. LDH release was defined as the ratio of LDH in the media to total LDH and normalized to the fold of control.
Cell death assessment. Following exposure of neuronal cultures to the various treatments, neuronal survival was quantified and presented as percent of cell death rate. Neuronal survival was determined by staining treated neuronal cultures with 5 mM Hoechst 33342 and 2 mM propidium iodide (PI) (Sigma) for 10 min. Culture plates were placed on a mechanized stage of a Nikon microscope (Nikon Corporation, Tokyo, Japan) and photomicrographs were collected by a blinded observer. The numbers of total and injured (PI positive) cells were counted by automated computer-assisted software (Image-Pro Plus version 6.0; Media Cybernetics Inc., Rockville, MD, USA). The raw counts are presented in an Excel file for the generation of percent cytotoxicity and statistical analysis.
Lentiviral preparation for RNAi and overexpression. For developing shRNA lentiviruses, an siRNA oligo directed to the coding region þ 1190-1208 was subcloned into a lentiviral expression vector, pFU-GW-RNAi (GeneChem Company, Shanghai, China). Following digestion and ligation, clones were selected and verified for the inserted sequence. The lentiviral construct coexpressed EGFP driven by the ubiquitin C promoter, in addition to U6 promoter driving the shRNA. To control for off-target and nonspecific effects of shRNA, a negative control shRNA (5 0 -TTCTCCGAACGTGTCACGT-3 0 ) was used. The overexpression of lentiviral system was developed by removing the EGFP open reading frame from the pGC-FU-EGFP-3FLAG construct (GeneChem Company) by an AgeI/NheI digestion and replacing it with the cDNA of Homer 1a. DNA fragments encoding mouse Homer 1a and human Homer 1a were PCR-amplified using mouse and human brain cDNA library as a template (Supplementary Figure S3 ).
Calcium imaging. Intracellular Ca 2 þ concentration were measured using the ratiometric calcium indicator Fura-2-AM (Invitrogen). Cultured neurons grown on glass slides were loaded with 5 mM Fura-2-AM for 45 min before glutamate treatment at room temperature. PKC activity assay. PKC activity assay was performed by using PKC kinase activity assay (Enzo Life Sciences, Farmingdale, NY, USA) following the manufacturer's protocol. Briefly, samples were added to wells of a PKC substrate microtiter plate pretreated with 50 ml of kinase assay dilution buffer for 10 min at room temperature. Ten microliters of diluted ATP was added to each well and incubated for 90 min at 30 1C. Then, supernatants were removed from each well and 40 ml of phosphospecific substrate antibody was added to each well for 60 min at room temperature. Each well was washed with washing buffer and 40 ml of diluted anti-rabbit IgG:HRP conjugate was added to each well for 30 min at room temperature. Later, each well was washed with washing buffer and 60 ml of TMB substrate was added to each well for 45 min at room temperature. Twenty microliters of acid stop solution was added to each well and the absorbance of the samples was measured by using a microplate reader.
Model of TBI in vivo. The in vivo model of TBI used in the present study was previously described by Flierl et al. 39 with some modifications. After induction of anesthesia with 4% isoflurane, a mouse was placed on the platform directly under the weight of the weight-drop device. A midline longitudinal scalp incision was made and the skull exposed. After identification of the right anterior frontal area (1.5 mm lateral to the midline in the mid-coronal plane) as impact area, the weight was released and dropped onto the skull. Then, the scalp wound was closed by standard suture material and the wound area was treated with lidocain cream. Mice were returned to cages at the end of the surgical procedures, where access to water and food was freely available.
Immunohistochemistry. The animals were transcardially perfused and postfixed with 4% paraformaldehyde in 0.1 M phosphate buffer. Brain tissues were embedded in paraffin. Serial sections were cut at 5 mm on a cryostat and mounted on the slides. For hematoxylin and eosin (H&E) staining, deparaffinized sections were stained with H&E according to the routine protocol. For immunostaining, deparaffinized sections were boiled in unmasking antigen buffer (10 mM sodium citrate buffer, pH 6.0) and incubated in 3% hydrogen peroxide for 10 min. After treating with blocking buffer for 1 h at room temperature, diluted primary antibody was added and incubated overnight at 4 1C. For DAB staining, sections were incubated with secondary antibodies (HRP-conjugated IgG) for 30 min. DAB dilution was added on sections and the reaction was stopped according to appropriate staining intensity. Sections were counterstained in hematoxylin. For double-labeled immunofluorescence staining, sections were incubated with secondary antibodies (Alexa 488 donkey-anti-goat IgG (Invitrogen), 1:300; Alexa-594-conjugated goat-anti-mouse IgG, 1:300) for 2 h. After staining, sections were coversliped with different mounting mediums. All the sections were observed using a fluorescence microscope (Olympus BX51, DP71).
Stereotaxic injection of lentivirus. Delivery of lentiviral vectors in vivo was carried out by using a stereotaxic cortical injection as described previously.
Three cortical injections were performed in the right hemisphere (ipsilateral to the lesion) as follows: point 1, 1.0 mm anterior to the bregma, 1.5 mm lateral, 1.5 mm deep; point 2, 0 mm anteroposterior to the bregma, 1.5 mm lateral, 1.5 mm deep; point 3, 1.0 mm posterior to the bregma, 1.5 mm lateral, 1.5 mm deep. All the target points were in the right hemisphere (ipsilateral to the lesion). Each injection contained 1.5 ml of 1 Â 10 9 TU/ml lentivirus suspension at a rate of 0.2 ml/min. The needle was withdrawn over a course of 10 min. Five days after injection of lentivirus, mice were subjected to brain trauma as described above.
Neurological severity score. The NSS highly correlates with the severity of brain damage and was measured as described previously. 39 NSS was conducted by an investigator who was blinded to the experimental groups. The score consists of 10 individual neurological parameters, including tasks on motor function, alertness and physiological behavior. One point is awarded for the lack of a tested reflex or for the inability to perform the tasks, and no point for succeeding. A maximal NSS of 10 points thus indicates severe neurological dysfunction, with failure of all tasks.
Water content measurement. The extent of cerebral edema is evaluated by determining the tissue water content in the injured hemisphere as reported previously. 39 Briefly, mice were decapitated under deep anesthesia with 100 mg/kg pentobarbital. The brains were quickly removed and the hemispheres were separated in the sagittal plane. Coronal sections of 3 mm thickness were prepared from the area bordering the lesion. These sections were weighed (wet weight, W w ) and dried in a desiccator oven for 24 h at 95 1C. After weighing the dried sections (dry weight, W d ), the water content was calculated as: % H 2 
Statistical analysis. All of the experiments were performed a minimum of three times. Statistical evaluation was carried out with GraphPad Prism software, version 5.0 (GraphPad, San Diego, CA, USA). Significant differences between experiments were assessed by univariate ANOVA (more than two groups), followed by Bonferroni's multiple comparisons or unpaired t-test (two groups).
